Recordati SpA (RCDTF)
58.79
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Recordati Price : 58.79 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 58.79 | 58.79 | 58.79 | 58.79 | 0.000 |
| Oct 05, 2026 | 58.79 | 58.79 | 58.79 | 58.79 | 0.000 |
| Oct 02, 2026 | 58.79 | 58.79 | 58.79 | 58.79 | 616.00 |
| Oct 01, 2026 | 58.79 | 58.79 | 58.79 | 58.79 | 750.00 |
| Sep 30, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 29, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 28, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 25, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 24, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 23, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 7.000 |
| Sep 22, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 21, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 18, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 17, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 16, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 15, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 14, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 11, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 10, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 09, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 08, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 04, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 03, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 02, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 0.000 |
| Sep 01, 2026 | 58.00 | 58.00 | 58.00 | 58.00 | 29.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 160.73 |
| ANI Pharmaceuticals, Inc. | 72.20 |
| Corcept Therapeutics, Inc. | 120.37 |
| Veru, Inc. | 2.48 |
| Avadel Pharmaceuticals Plc | 21.64 |
Price Related Metrics
| PE Ratio | 21.17 |
| PS Ratio | 3.892 |
| PEG Ratio | 0.6766 |
| Price to Book Value | 4.943 |
| Price to Free Cash Flow | 19.92 |
| Earnings Yield | 4.72% |
| Market Cap | 12.04B |
| PEGY Ratio | 0.6237 |
| Operating PE Ratio | 13.03 |
| Normalized PE Ratio | 19.89 |